Literature DB >> 20053348

Osteopontin provides early proliferative drive and may be dependent upon aberrant c-myc signalling in murine intestinal tumours.

Cristina Martinez1, Michael Churchman, Tom Freeman, Mohammad Ilyas.   

Abstract

Osteopontin is thought to play an important role in tumour metastasis. In a previous expression profiling study of murine intestinal adenomas, we found that Opn was up-regulated. We also found beta-catenin binding motifs in the Opn promoter implying that, contrary to current beliefs, induction of Opn may occur during early tumourigenesis. We studied 59 murine intestinal adenomas for Opn expression and every tumour showed up-regulation compared to normal mucosa confirming early deregulation in these tumours. To determine whether Opn makes a functional contribution to tumourigenesis, Opn was knocked down in the murine colorectal cancer cell line CMT93. Inhibition of Opn expression resulted in decreased cell numbers. To determine the mechanism of Opn induction in these tumours, the Opn promoter was cloned and each of the putative beta-catenin binding motifs was mutated. No major change in Opn promoter activity was observed thereby excluding Opn as a direct beta-catenin target gene. However, mutation of one of two putative c-myc binding sites in the Opn promoter led to near complete loss of promoter activity whilst mutation of one of four PEA3 binding sites led to a 50% reduction in promoter activity. We conclude that Opn deregulation is an early event in intestinal tumourigenesis which may promote tumour development by altering either proliferation or apoptosis to increase tumour cell numbers. Opn expression in the intestine is dependent on c-myc binding sites in the promoter. Since c-myc is a known beta-catenin target gene, deregulation of Opn may be a secondary effect of aberrant Wnt signalling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053348     DOI: 10.1016/j.yexmp.2009.12.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  The potential of osteopontin as a therapeutic target for human colorectal cancer.

Authors:  Wang Likui; Wang Hong; Zhang Shuwen; You Yuangang; Wen Yan
Journal:  J Gastrointest Surg       Date:  2011-02-12       Impact factor: 3.452

Review 2.  MYC and metastasis.

Authors:  Anita Wolfer; Sridhar Ramaswamy
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

3.  Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.

Authors:  Aruz Mesci; Samira Taeb; Xiaoyong Huang; Rishi Jairath; Darshan Sivaloganathan; Stanley K Liu
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

4.  Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.

Authors:  Lucas Novaes Teixeira; Larissa Moreira Spinola de Castro Raucci; Gabriela Caroline Alonso; Ricardo Della Coletta; Adalberto Luiz Rosa; Paulo Tambasco de Oliveira
Journal:  Tumour Biol       Date:  2016-06-16

5.  The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs.

Authors:  Eman Sami; Danielle Bogan; Alfredo Molinolo; Jim Koziol; Wael M ElShamy
Journal:  Cancer Gene Ther       Date:  2021-03-15       Impact factor: 5.987

Review 6.  MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.

Authors:  Erna Marija Meškytė; Sabiha Keskas; Yari Ciribilli
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.